EchoGo® Heart Failure vs Rapid PE Triage and Notification (PETN)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent rather than direct competitors, as they address distinct cardiac conditions using different imaging modalities. EchoGo® Heart Failure analyzes echocardiograms for HFpEF detection, while Rapid PE Triage and Notification processes CTPA images for suspected pulmonary embolisms. Both offer AI-powered insights for cardiology and emergency medicine, but serve different diagnostic pathways.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is designed to detect Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing routine echocardiograms. Rapid PE Triage and Notification (PETN) focuses on rapidly identifying suspected central pulmonary embolisms (PE) through the analysis of CTPA images.
EchoGou00ae Heart Failure analyzes routine echocardiogram video clips to provide insights. Rapid PE Triage and Notification (PETN) utilizes AI/ML to analyze CTPA images for the detection of suspected central pulmonary embolisms.
EchoGou00ae Heart Failure delivers insights within 20 minutes and provides automated structured reports via a DICOM workflow to PACS. Rapid PE Triage and Notification (PETN) offers workflow triage and prioritization, sending real-time notifications to clinicians via PACS, email, or a mobile app, and operates in parallel with the standard of care.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. Pricing for Rapid PE Triage and Notification (PETN) is not publicly disclosed and is typically based on enterprise-level licensing.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection, and it is FDA-cleared. Rapid PE Triage and Notification (PETN) is FDA-cleared for the fast identification and communication of suspected central pulmonary embolism, but specific sensitivity and specificity metrics are not provided in the given information.
EchoGou00ae Heart Failure is designed to support Cardiology, Emergency Medicine, and Internal Medicine specialties. Rapid PE Triage and Notification (PETN) targets Cardiology, Emergency Medicine, and Radiology specialties.